Cytokinetics | CYTK - Current Liabilities


Cytokinetics reported $142.14M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 356.58M 26.56M Sep/2025
Amgen USD 25.49B 3.7B Dec/2025
Arca Biopharma USD 20.97M 8.86M Sep/2025
Bayer EUR 28.96B 825M Sep/2025
Biogen USD 3.35B 59.4M Dec/2025
Brainstorm Cell Therapeutics USD 9.02M 495K Sep/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Capricor Therapeutics USD 28.15M 249K Sep/2025
Cytokinetics USD 142.14M 11.08M Sep/2025
Eisai JPY 387.67B 9.42B Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Exelixis USD 405.64M 31.86M Dec/2025
Geron USD 87.71M 23.43M Sep/2025
Halozyme Therapeutics USD 177.09M 660.14M Dec/2025
Ionis Pharmaceuticals USD 903.46M 6.22M Sep/2025
Ligand Pharmaceuticals USD 30.54M 34.2M Sep/2025
Merck USD 28.63B 2.59B Sep/2025
Novartis USD 32B 286M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025